Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and specialty care. The group develops and commercializes innovative medicines in three key therapeutic areas – Neurosciences, Oncology and Rare Diseases. At Ipsen we have pioneered research in the area of neuroscience for decades and remain committed to providing patients with innovative therapeutic solutions. A primary focus at Ipsen is to progress the development of new medicines in the treatment of neurological disorders. Our work in neurology is wide-ranging, with much of our research focused on improving the care of people with debilitating movement disorders.